Metabolic syndrome does not raise a mans risk of developing prostate cancer overall, but does raise their risk of aggressive prostate cancer, according to a report presented at the 27th Annual Congress of the European Association of Urology.
A new study shows that when men with prostate cancer were diagnosed after developing symptoms rather than after screening tests, they had a higher risk of dying from heart problems or other cancers rather than the prostate cancer itself.
Avodart, a popular drug used to treat an enlarged prostate gland could have an additional benefit. Research shows it helps slow the progression of early-stage prostate cancer, thus reducing the need for aggressive treatment in some men.
It appears that you already have an account created within our VIP network of sites on .
To keep your personal information safe, we need to verify that it's really you.
To activate your account, please confirm your password.
When you have confirmed your password, you will be able to log in through Facebook on both sites.
*Please note that your prizes and activities will not be shared between programs within our VIP network.
Welcome back to WIBX 950
It appears that you already have an account on this site associated with . To connect your existing account just click on the account activation button below. You will maintain your existing VIP profile. After you do this, you will be able to always log in to http://wibx950.com using your original account information.